Product: SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Reason for recall: Marketed Without an Approved NDA/ANDA: FDA analysis  revealed the presence of undeclared meloxicam.
Recall initiated: 20251020
Status: Ongoing
Classification: Class I
Recall type: Voluntary: Firm initiated